We have collected information about Antisense Therapy Delivery for you. Follow the links to find out details on Antisense Therapy Delivery.
https://www.sciencedirect.com/science/article/pii/S0169409X15000435
In rats, intranasal delivery of antisense oligonucleotides was found to lead to good distribution throughout the brain, and was able to slow down intracerebral tumour growth . These studies hence indicate that intranasal delivery may become a viable option for antisense oligonucleotide delivery in the future. 3. Chemical modificationsAuthor: Melvin M. Evers, Lodewijk J.A. Toonen, Willeke M.C. van Roon-Mom
https://www.nature.com/articles/nrneurol.2017.148
Dec 01, 2017 · Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and ... A. Nanoparticle delivery of antisense oligonucleotides and their application in the exon skipping strategy ...Author: C Rinaldi, Wood Mja.
https://www.sciencedirect.com/topics/neuroscience/antisense-oligonucleotide
Antisense oligonucleotide therapy has gained popularity since the late 1980s. Advances in this field are directly related to improved technology, allowing synthesis of research quantities of oligonucleotides and the explosive growth of knowledge of viral, animal, and human genomic sequences.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2475625/
Jun 16, 2008 · The potential use of antisense and siRNA oligonucleotides as therapeutic agents has elicited a great deal of interest. However, a major issue for oligonucleotide-based therapeutics involves effective intracellular delivery of the active molecules.Author: Rudy Juliano, Md. Rowshon Alam, Vidula Dixit, Hyumin Kang
https://www.intechopen.com/books/antisense-therapy/applications-of-lipidic-and-polymeric-nanoparticles-for-sirna-delivery
The antisense technology that emerged with the discovery of RNA interference nearly 20 years ago has gained a significant place in gene therapy. siRNA, one of two important components of RNA interference, efficiently downregulates gene expression in human cells, so it has the potential to eradicate disease. siRNA delivery systems, which can be applied both systemically and locally in different ...Author: Behiye Şenel, Gülay Büyükköroğlu
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251390/
Aug 02, 2013 · Although promising, the headway of antisense therapy in the clinical realm has been quite slow. To better appreciate the current status of AO drug therapies, it is important to consider the hurdles that AOs have had to overcome. The first of these hurdles is drug delivery.Author: Joshua J. A. Lee, Toshifumi Yokota
https://www.intechopen.com/books/antisense-therapy/antisense-therapy-an-overview
The main obstacles that remained in cancer gene therapy and antisense therapy are the lack of delivery systems that successfully deliver an efficacious dose of a therapeutic gene (s) or antisense drug(s) to the targeted tumor site. Targeted gene or antisense drug delivery to distant tumors for therapeutic approaches is a demanding task that ...Author: Shashwat Sharad
https://www.prnewswire.com/news-releases/global-markets-for-drug-delivery-in-cancer-forecast-to-2028---includes-coverage-on-antisense-rnai-and-gene-therapy-for-cancer-301022330.html
Global Markets for Drug Delivery in Cancer, Forecast to 2028 - Includes Coverage on Antisense, RNAi and Gene Therapy for Cancer
Searching for Antisense Therapy Delivery?
You can just click the links above. The data is collected for you.
